Details for 2021192925
Up to date per 28.05.2026
Actions
Details for 2021192925
Deleted
European Patent
16.03.2022 A
27.03.2024 B1
19.12.2014
US
201462094943 P
02.11.2015
US
201562249781 P
A61K 38/46 20060101AFI20230907BHEP
Owner
Inozyme Pharma, Inc.321 Summer Street, Suite 400 Boston, MA 02210US
Representative
No representatives present
Inventor
QUINN, Anthony Gloucester, Massachusetts 01930US
HSIA, Nelson Cambridge, Massachusetts 02138US
ASKEW, Kim Lynette Lincoln, Massachusetts 01773-5011US
GRABOWSKI, Gregory Wheat Ridge, CO 80033US
O'NEILL, W. Charles Decatur, Georgia 30030US
KHAN, Tayeba Lexington, Massachusetts 02421US
CHENG, Zhiliang Cheshire, Connecticut 06410US